Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 3 Fluoro 2 Methyl 4 Trifluoromethylaniline Hydrochloride. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110885290A discloses a novel route for 3-fluoro-2-methyl-4-trifluoromethylaniline hydrochloride via Buchwald-Hartwig amination, ensuring high purity and scalable production for pharmaceutical intermediates.